BIOSCIENCE NEUTRACEUTICALS, INC. Deferred Tax Assets, Valuation Allowance
BIOSCIENCE NEUTRACEUTICALS, INC. had Deferred Tax Assets, Valuation Allowance of -$53.16 thousand as of 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2020-03-30
- 2019-12-31: Deferred Tax Assets, Valuation Allowance -$53.16K.
- 2018-12-31: Deferred Tax Assets, Valuation Allowance $39.13K.
- 2017-12-31: Deferred Tax Assets, Valuation Allowance $28.13K; Deferred Tax Assets, Valuation Allowance as first filed $45.55K.
- 2016-12-31: Deferred Tax Assets, Valuation Allowance $32.26K.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2019-12-31 | -$53.16K 10-K · filed 2020-03-30 | |
| 2018-12-31 | $39.13K 10-K · filed 2020-03-30 | |
| 2017-12-31 | $28.13K 10-K · filed 2019-04-09 | $45.55K 10-K · filed 2018-04-12 |
| 2016-12-31 | $32.26K 10-K · filed 2018-04-12 | |
| 2016-09-30 | $31.14K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $30.19K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $28.66K 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $27.48K 10-K · filed 2017-03-31 | |
| 2015-09-30 | $26.51K 10-Q · filed 2015-10-29 | |
| 2015-06-30 | $25.50K 10-Q · filed 2015-07-28 | |
| 2015-03-31 | $27.48K 10-Q · filed 2016-05-11 | $12.42K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $11.16K 10-K · filed 2016-03-28 | |
| 2014-09-30 | $10.12K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $7.29K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $5.68K 10-Q · filed 2014-06-20 | |
| 2013-12-31 | $4.83K 10-K · filed 2015-03-12 |